Zealand Pharma A/S (ZEAL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.070x

Based on the latest financial reports, Zealand Pharma A/S (ZEAL) has a cash flow conversion efficiency ratio of -0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-1.04 Billion ≈ $-163.16 Million USD) by net assets (Dkr14.83 Billion ≈ $2.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ZEAL market cap for the company's overall valuation and market capitalisation.

Zealand Pharma A/S - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Zealand Pharma A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zealand Pharma A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zealand Pharma A/S ranked by their cash flow conversion efficiency. Explore cash flow quality index of Zealand Pharma A/S to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CITY DEV.LTD.ADR/1 SD-50 F:CDE0	N/A
Sinomag Technology Co Ltd SHE:300835	0.011x
FangDa Carbon New Material Co Ltd SHG:600516	-0.012x
Petrosea Tbk JK:PTRO	-0.024x
IAC Inc. NASDAQ:IAC	0.003x
Tasly Pharmaceutical Group Co Ltd SHG:600535	0.043x
Bank of Queensland Ltd AU:BOQ	0.082x
Aalberts Industries NV AS:AALB	0.047x

Annual Cash Flow Conversion Efficiency for Zealand Pharma A/S (2007–2025)

The table below shows the annual cash flow conversion efficiency of Zealand Pharma A/S from 2007 to 2025. View ZEAL stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr14.83 Billion ≈ $2.32 Billion	Dkr6.53 Billion ≈ $1.02 Billion	0.440x	+507.72%
2024-12-31	Dkr8.62 Billion ≈ $1.35 Billion	Dkr-930.82 Million ≈ $-145.63 Million	-0.108x	+59.58%
2023-12-31	Dkr1.59 Billion ≈ $249.21 Million	Dkr-425.67 Million ≈ $-66.60 Million	-0.267x	+76.86%
2022-12-31	Dkr815.91 Million ≈ $127.66 Million	Dkr-942.21 Million ≈ $-147.42 Million	-1.155x	+11.60%
2021-12-31	Dkr927.80 Million ≈ $145.16 Million	Dkr-1.21 Billion ≈ $-189.62 Million	-1.306x	-123.26%
2020-12-31	Dkr1.18 Billion ≈ $184.16 Million	Dkr-688.72 Million ≈ $-107.75 Million	-0.585x	-77.57%
2019-12-31	Dkr1.24 Billion ≈ $194.43 Million	Dkr-409.45 Million ≈ $-64.06 Million	-0.329x	+20.11%
2018-12-31	Dkr1.12 Billion ≈ $174.65 Million	Dkr-460.40 Million ≈ $-72.03 Million	-0.412x	+21.81%
2017-12-31	Dkr528.47 Million ≈ $82.68 Million	Dkr-278.75 Million ≈ $-43.61 Million	-0.527x	-458.73%
2016-12-31	Dkr278.19 Million ≈ $43.53 Million	Dkr40.90 Million ≈ $6.40 Million	0.147x	+116.45%
2015-12-31	Dkr252.23 Million ≈ $39.46 Million	Dkr-225.41 Million ≈ $-35.27 Million	-0.894x	-435.63%
2014-12-31	Dkr252.83 Million ≈ $39.56 Million	Dkr-42.18 Million ≈ $-6.60 Million	-0.167x	+68.90%
2013-12-31	Dkr316.14 Million ≈ $49.46 Million	Dkr-169.62 Million ≈ $-26.54 Million	-0.537x	-484.38%
2012-12-31	Dkr491.01 Million ≈ $76.82 Million	Dkr68.54 Million ≈ $10.72 Million	0.140x	+3511.47%
2011-12-31	Dkr441.40 Million ≈ $69.06 Million	Dkr-1.81 Million ≈ $-282.56K	-0.004x	+97.02%
2010-12-31	Dkr407.11 Million ≈ $63.70 Million	Dkr-55.98 Million ≈ $-8.76 Million	-0.138x	+70.26%
2009-12-31	Dkr132.92 Million ≈ $20.80 Million	Dkr-61.45 Million ≈ $-9.61 Million	-0.462x	-237.00%
2008-12-31	Dkr208.63 Million ≈ $32.64 Million	Dkr-28.62 Million ≈ $-4.48 Million	-0.137x	+42.25%
2007-12-31	Dkr242.37 Million ≈ $37.92 Million	Dkr-57.57 Million ≈ $-9.01 Million	-0.238x	--

About Zealand Pharma A/S

CO:ZEAL Denmark Biotechnology

Market Cap

$3.05 Billion

Dkr19.53 Billion DKK

Market Cap Rank

#4865 Global

#30 in Denmark

Share Price

Dkr277.20

Change (1 day)

-0.54%

52-Week Range

Dkr234.90 - Dkr545.80

All Time High

Dkr954.00